Currenc Group Inc (CURR) Stock Price, Quote & News

Latest News on CURR

Mar 27, 2025, 8:45 AM EDT - 6 days ago

CURRENC Empowers Coin Cove with AI-Powered Electronic Banking Services Platform

Mar 27, 2025, 8:15 AM EDT - 6 days ago

CURRENC's SEAMLESS AI Lab Unveils “AI Staff for Hire” Platform

Mar 18, 2025, 11:46 AM EDT - 15 days ago

CURRENC to Develop 500MW Hyperscale AI Data Center in Malaysia

Mar 18, 2025, 11:45 AM EDT - 15 days ago

CURRENC Group and ARC Group Jointly Launch $100 Million AI-Focused Infrastructure & Investment Fund

Mar 13, 2025, 8:00 AM EDT - 20 days ago

CURRENC to Participate in the AI Panel at the 37th Annual ROTH Conference

Jan 8, 2025, 7:00 AM EST - 3 months ago

CURRENC Debuts SEAMLESS AI Call Centre Solutions

Nov 29, 2024, 7:00 AM EST - 4 months ago

CURRENC Group Inc. Announces Third Quarter 2024 Unaudited Financial Results

Sep 26, 2024, 5:05 PM EDT - 6 months ago

CURRENC Rings Nasdaq Closing Bell in Honor of Listing

Aug 15, 2023, 6:00 AM EDT - 1 year ago

Avenir Wellness Solutions Reports Second Quarter 2023 Results

Aug 8, 2023, 3:25 PM EDT - 1 year ago

Avenir Wellness Solutions Announces New Ticker Symbol As Final Part of Exciting New Brand Identity

Jul 31, 2023, 6:00 AM EDT - 1 year ago

Avenir Wellness Solutions Reports First Quarter 2023 Results with Strong Sequential and Year Over Year Revenue Increases and Continued High Gross Margins

May 17, 2023, 6:00 AM EDT - 2 years ago

Avenir Wellness Solutions Update to Stockholders

Apr 26, 2023, 3:15 PM EDT - 2 years ago

Avenir Wellness Solutions (OTCQB:CURR) to Present at the Planet MicroCap Showcase - Live Webcast Available

Apr 25, 2023, 6:00 AM EDT - 2 years ago

Avenir Wellness Letter to Stockholders

Mar 16, 2023, 12:20 PM EDT - 2 years ago

Avenir's Sera Labs Launches Patent Pending DNA Complex with Advanced Peptides and Compounds - Providing Instant and Long-Lasting Results With Daily Use

Feb 13, 2023, 9:00 AM EST - 2 years ago

Avenir Wellness Solutions, Inc. Gains High Profile Exposure on theSkimm Social Media Platform With 7 Million Followers and Launches New Website in Support of Corporate Rebranding

Jan 19, 2023, 9:00 AM EST - 2 years ago

Avenir Wellness Solutions to Launch Wall Street-focused Informational Series with Producer New to The Street

Jan 17, 2023, 9:00 AM EST - 2 years ago

CURE Pharmaceutical Unveils Exciting New Brand Identity with Name Change to Avenir Wellness Solutions, Inc.

Dec 15, 2022, 9:00 AM EST - 2 years ago

CURE Pharmaceutical Letter to Shareholders

Nov 22, 2022, 6:00 AM EST - 2 years ago

CURE Pharmaceutical Reports Third Quarter 2022 Results With Strong Sequential and Year Over Year Revenue Increases and Continued High Margins

Nov 10, 2022, 7:30 PM EST - 2 years ago

Avenir Wellness Solutions to Present at Investor Summit Group's Q4 Conference

Oct 24, 2022, 7:30 AM EDT - 2 years ago

Cure Pharmaceutical Holding to Present at the LD Micro Main Event XV

Sep 2, 2022, 6:00 AM EDT - 2 years ago

Cure Pharmaceutical Reports Second Quarter 2022 Results With Increased Sequential Revenues and Strong Margins

Aug 16, 2022, 6:00 AM EDT - 2 years ago

CURE Pharmaceutical Announces Rob Davidson as new Chairman of the Board and Appointment of Rob Costantino as Member of the Board and Audit Committee Chairman

Aug 9, 2022, 9:00 AM EDT - 2 years ago

CURE Pharmaceutical Provided Full Corporate Update on Recent Shareholder Call

Aug 2, 2022, 9:00 AM EDT - 2 years ago

CURE Pharmaceutical Announces the Appointment of New Board Member

Aug 1, 2022, 9:00 AM EDT - 2 years ago

CURE Pharmaceutical Announces Teleconference With Investors

Jul 28, 2022, 9:00 AM EDT - 2 years ago

CURE Pharmaceutical Announces the Sale of a Portion of its Platform Technology IP for $20 Million

May 12, 2022, 1:42 PM EDT - 3 years ago

CURE Pharmaceutical Announces Positive Findings from Study at Cincinnati Children's Hospital Medical Center (CCHMC) Using CURE's Proprietary, Oral Thin Film (OTF) High, Single Dose Vitamin D in Pediatric Patients Pre- and Post-Hematopoietic Stem Cell Tran

Mar 3, 2022, 11:18 AM EST - 3 years ago

CURE Pharmaceutical and Milagro Pharmaceuticals Collaborate for Registration and Approval to Sell Sildenafil Oral Thin Film in Mexico

Dec 9, 2021, 7:30 AM EST - 3 years ago

Sera Labs, a Subsidiary of CURE Pharmaceutical, Consummates Exclusive International Distribution Agreement With Leading Canadian Distributor

Nov 16, 2021, 7:30 AM EST - 3 years ago

CURE Pharmaceutical Receives Patent Approval for Its CUREfilm Blue™ Technology

Aug 18, 2021, 9:27 AM EDT - 3 years ago

CURE Pharmaceutical Q2 2021 Revenue Spikes 700% After Increased Sales From Seba Labs Products Including A CVS Deal

Aug 17, 2021, 8:00 AM EDT - 3 years ago

CURE Pharmaceutical Reports Second Quarter 2021 Revenue Rose Nearly 700% Driven by Sales from Sera Labs Product Lines

Aug 4, 2021, 7:00 AM EDT - 3 years ago

Seratopical Revolution Skincare Line by The Sera Labs Inc., a CURE Pharmaceutical Company, will be Available for Purchase this Fall at CVS, one of the Leading National Drug Store Chains

Jun 15, 2021, 8:15 AM EDT - 4 years ago

CURE Pharmaceutical to Present at H.C. Wainwright 2021 Psychedelics in Psychiatry and Beyond Virtual Conference

Jun 11, 2021, 3:48 PM EDT - 4 years ago

Federally Compliant Medical Cannabis In The US? One Company Is Doing It

Jun 10, 2021, 8:15 AM EDT - 4 years ago

CURE Pharmaceutical Signs Agreement to Develop CBD and THC Oral Thin Films and Conduct Clinical Studies Targeting Veteran Health

May 25, 2021, 9:00 AM EDT - 4 years ago

CURE Pharmaceutical Schedules Investor Webcast for Thursday, May 27, 2021

May 17, 2021, 9:15 AM EDT - 4 years ago

CURE Pharmaceutical First Quarter Revenue Quadruples to $1.5 million; Company Expands Clinical Pipeline to Include Psychedelics

May 13, 2021, 8:15 AM EDT - 4 years ago

CURE Pharmaceutical Receives ISO Certification for Laboratory and Manufacturing Facility

Apr 19, 2021, 8:30 AM EDT - 4 years ago

CURE Pharmaceutical to Present at the 2021 Sequire Cannabis Conference on Tuesday, April 20, at 2 p.m. EDT/11 a.m.

Apr 1, 2021, 8:30 AM EDT - 4 years ago

CURE Pharmaceutical Reports Increase in Revenue to $7.7 Million on a Pro Forma Basis in 2020

Mar 23, 2021, 8:30 AM EDT - 4 years ago

CURE Pharmaceutical Augments Its Existing U.S. DEA License in Order to Initiate Development of Its Psychedelics-Based Pharmaceutical Clinical Pipeline

Mar 16, 2021, 8:45 AM EDT - 4 years ago

CURE Pharmaceutical Launches Psychedelic Oral Film Program Targeting the Treatment of Mental Health Disorders

Mar 10, 2021, 8:15 AM EST - 4 years ago

CURE Pharmaceutical Announces Addition of Two New Clinical Development Programs Targeting Anti-Seizure and Antiviral Applications

Mar 3, 2021, 8:15 AM EST - 4 years ago

CURE Pharmaceutical's Subsidiary Sera Labs Launches National Television, Radio & Digital Advertising Campaign for Nutri-Strips Sleep A.S.A.P.

Feb 11, 2021, 8:15 AM EST - 4 years ago

CURE Pharmaceutical Announces Promotions and Additions to Board of Directors

Feb 10, 2021, 9:31 AM EST - 4 years ago

Sera Labs Unveils ImmunD₃™ an Important New Offering to the Nutri-Strips™ Product Line; Launches New Digital E-commerce Website to Amplify Consumer Awareness

Feb 2, 2021, 8:30 AM EST - 4 years ago

Market Cap	73.05M
Revenue (ttm)	4.90M
Net Income (ttm)	-25.51M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-520.61%
Debt to Equity Ratio	0.00

Volume	68,400
Avg Vol	516,522
Day's Range	N/A - N/A
Shares Out	46.53M
Stochastic %K	49%
Beta	-0.17
Analysts	Strong Sell
Price Target	$3.50